Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents– a real-world cross-sectional study from Switzerland (SAKK 95/16)

Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents– a real-world cross-sectional study from Switzerland (SAKK 95/16)

Abstract Background Bone-targeted agents (BTAs) are widely used in the management of patients with bone metastases from solid tumors. Knowledge of the impact of their routine care use on patient-reported pain and bone pain-related quality of life (QoL) is limited. Methods This real world, cross-sect...

Full description

Bibliographic Details
Main Authors: Karin Ribi, Beat Thürlimann, Corinne Schär, Daniel Dietrich, Richard Cathomas, Ursina Zürrer-Härdi, Thomas von Briel, Sandro Anchisi, Pierre Bohanes, Veronika Blum, Philippe von Burg, Meinrad Mannhart, Clemens B. Caspar, Roger von Moos, Michael Mark
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Cancer
Subjects:
Bone metastases
Bone-targeting agents
Patient-reported pain
Bone-pain related quality of life
Non-interventional
Patterns of care
Online Access:https://doi.org/10.1186/s12885-021-07903-8

Internet

https://doi.org/10.1186/s12885-021-07903-8

Similar Items